In a study in mice, researchers successfully performed stem cell transplants without first using radiation or chemotherapy. If this method also works in humans, this treatment could be used in patients who are not able to receive the high doses of radiation and chemotherapy usually given before a transplant.
The NCI-supported Childhood Cancer Survivor Study has helped to identify late effects of childhood cancer treatments and to develop ways to prevent or manage these effects. Greg Armstrong, M.D., of St. Jude Children’s Research Hospital, is the principal investigator of this study. In this interview, he discusses some recent findings from the long-running study and its future directions.
We've updated our PDQ summary with recent statistics on smoking and added information about a study that shows that getting counseling from a doctor, taking part in group sessions with other smokers, and using nicotine gum help people quit smoking.
We've added information to our PDQ skin cancer prevention summary about a study that shows the use of nicotinamide (vitamin B3) helps prevent new actinic keratosis lesions in some people who already have actinic keratosis. Actinic keratosis is a risk factor for skin cancer.
We've added a new drug summary for propranolol, which is used to treat hemangiomas (benign blood vessel tumors) in infants. It is also used to treat high blood pressure and other conditions.
We've added a new summary about the drug combination called R-ICE. It is used to treat certain types of non-Hodgkin lymphoma (NHL). The combination includes the drugs rituximab, ifosfamide, carboplatin, and etoposide.
Progress against pediatric cancer requires long-term investment in basic research. Basic research provides the necessary foundation for tomorrow’s scientific and clinical advances.
September is Prostate Cancer Awareness Month. Learn the basics about prostate cancer, including what it is, how it is detected and treated, statistics, and the results of research studies.
